| Clinical data | |
|---|---|
| Other names | [(2R,3S,4S,5R)-3,4-dihydroxy-2,5,6-tris(methylsulfonyloxy)hexyl] methanesulfonate |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C10H22O14S4 |
| Molar mass | 494.51 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Mannosulfan (INN) is analkylating agent with the potential for the treatment ofcancer. It is not approved by the United States FDA for cancer treatment. Research suggests it is less toxic than the alkyl sulfonateBusulfan.[1]
Thisantineoplastic orimmunomodulatorydrug article is astub. You can help Wikipedia byadding missing information. |